|
| |
|
1.Manufacturing Perspectives
Johan Vandersande
Baxter BioScience, U.S.A. |
|
4.Applications of Plasma Products and Clinical Developments
Juan I. Jorquera, Instituto Grifols S.A., Spain |
| |
|
|
2.
Quality and Regulatory Trends
Andra Buchacher, Octapharma PPgmbH, Austria |
|
5.Commercial and Market Trends
John Curling, John Curling Consulting AB, Sweden |
| |
|
|
3.Pathogen Safety
Hannelore Willkommen, Reg Affairs & Biol Safety Consulting, Germany |
|
6.
New Products & Innovations in Plasma Processing
Claudia Nardini, Kedrion S.p.A., Italy |
| |
|
|
| |
|
Jean-François Prost
LFB Biotechnologies, France |
|
Yehuda Shoenfeld
Chaim Sheba Medical Center, Israel |
|
|
